[HTML][HTML] Current and emerging markers and tools used in the diagnosis and management of chronic kidney disease–mineral and bone disorder in non-dialysis adult …
M Fusaro, L Pereira, J Bover - Journal of Clinical Medicine, 2023 - mdpi.com
Chronic kidney disease (CKD) is a significant public health concern associated with
significant morbidity and has become one of the foremost global causes of death in recent …
significant morbidity and has become one of the foremost global causes of death in recent …
[HTML][HTML] FGF-23 and sclerostin in serum and bone of CKD patients
F Lima, MC Monier-Faugere, H Mawad… - Clinical …, 2023 - ncbi.nlm.nih.gov
Aims: Renal osteodystrophy occurs in the early stages of chronic kidney disease (CKD) and
progresses during loss of kidney function. Fibroblast growth factor (FGF)-23 and sclerostin …
progresses during loss of kidney function. Fibroblast growth factor (FGF)-23 and sclerostin …